trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

PrEP is effective for protecting against HIV acquisition.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
8 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that PrEP is effective for protecting against HIV acquisition?

Yes. Pre-exposure prophylaxis (PrEP) is strongly supported by clinical and epidemiological evidence as an effective biomedical intervention for protecting against HIV acquisition.

Verdict: SUPPORTED · 8 sources for, 0 against · Last checked

The analysis

The claim that PrEP is effective for protecting against HIV acquisition is an empirical and well-established scientific fact. Multiple retrieved papers, including systematic reviews, meta-analyses, and clinical modeling studies, confirm that PrEP substantially reduces the risk of HIV acquisition when taken effectively. There are no papers refuting its efficacy.

Evidence for · 8
Optimizing HIV Spending Among Key Populations in Five Latin American and Caribbean Countries: A Mathematical Modelling Study.
2026
The study models and optimizes interventions, including PrEP, to reduce cumulative HIV acquisitions and mortality.
Get citation
D, T. B., AL, B., R, M., N, W., K, B., CY, R. H., R, L. N., B, C., RV, S., JP, M. C., SM, N. R., M, P. B., & N, S. (2026). Optimizing HIV Spending Among Key Populations in Five Latin American and Caribbean Countries: A Mathematical Modelling Study.. doi.org. https://doi.org/10.1002/jia2.70171

See more details
More for · 7
A Human Right to HIV Prevention: Pre-Exposure Prophylaxis and the Right to Health
2022
The article describes PrEP as a medicine that provides almost complete protection against HIV infection.
Get citation
Bhatt, V. (2022). A Human Right to HIV Prevention: Pre-Exposure Prophylaxis and the Right to Health. doi.org. https://doi.org/10.2139/ssrn.3976856

Using the social ecological model to understand the factors that influence the attitudes women have towards the use of pre-exposure prophylaxis for the prevention of HIV in Uganda.
2026
The study notes that biomedical interventions like PrEP are effective in reducing HIV infection in high-risk groups.
Get citation
GM, K. & R, H. (2026). Using the social ecological model to understand the factors that influence the attitudes women have towards the use of pre-exposure prophylaxis for the prevention of HIV in Uganda.. doi.org. https://doi.org/10.1080/09540121.2026.2728928

Quantitative systems pharmacology of HIV PrEP and PEP.
2026
The review examines the quantitative systems pharmacology of PrEP and its prophylactic efficacy in preventing HIV.
Get citation
S, I., L, Z., A, L., HY, K., & M, v. K. (2026). Quantitative systems pharmacology of HIV PrEP and PEP.. doi.org. https://doi.org/10.1080/17425255.2026.2715711

Adding a Prevention Intervention to an Established App: The Blued+ HIV Prevention Pilot Study in Beijing and Chengdu, China.
2026
The pilot study evaluates telePrEP care and finds increased PrEP use and positive preliminary efficacy in HIV prevention.
Get citation
AJ, S., G, M., F, Y., D, S., K, N., SHE, K., Y, L., KA, P., S, B., PS, S., & W, H. (2026). Adding a Prevention Intervention to an Established App: The Blued+ HIV Prevention Pilot Study in Beijing and Chengdu, China.. doi.org. https://doi.org/10.1002/jia2.70203

Effectiveness, safety, adherence and risk compensation of oral pre-exposure prophylaxis (PrEP) in men who have sex with men: a systematic review and meta-analysis.
2026
The systematic review and meta-analysis demonstrate that PrEP is associated with a significant relative risk reduction in HIV acquisition.
Get citation
C, X., K, Q., Q, H., Y, Z., Q, Y., M, Z., N, L., R, H., S, W., & B, Y. (2026). Effectiveness, safety, adherence and risk compensation of oral pre-exposure prophylaxis (PrEP) in men who have sex with men: a systematic review and meta-analysis.. doi.org. https://doi.org/10.1136/bmjebm-2025-113648

Cost-effectiveness of lenacapavir versus tenofovir disoproxil fumarate plus emtricitabine for pre-exposure prophylaxis to prevent HIV-1 transmission in gay, bisexual, and other men who have sex with men in Spain.
2026
The cost-effectiveness analysis notes that new forms of PrEP have demonstrated superior efficacy over older regimens in clinical trials.
Get citation
PE, W., C, I., M, R., V, E., F, P., JA, P., & J, L. (2026). Cost-effectiveness of lenacapavir versus tenofovir disoproxil fumarate plus emtricitabine for pre-exposure prophylaxis to prevent HIV-1 transmission in gay, bisexual, and other men who have sex with men in Spain.. doi.org. https://doi.org/10.1016/j.lanepe.2026.101807

Cost-effectiveness of providing pre-exposure and post-exposure prophylaxis for the prevention of HIV via online pharmacies in western Kenya: a modelling study.
2026
The modeling study evaluates online PrEP distribution as a strategy to increase biomedical HIV prevention coverage and avert infections.
Get citation
A, M., N, P., D, K., Y, C., C, A., A, S., C, K., T, K., K, N., KF, O., & M, S. (2026). Cost-effectiveness of providing pre-exposure and post-exposure prophylaxis for the prevention of HIV via online pharmacies in western Kenya: a modelling study.. doi.org. https://doi.org/10.1016/j.langlo.2026.103977

What does the evidence say?

The claim that PrEP is effective for protecting against HIV acquisition is an empirical and well-established scientific fact. Multiple retrieved papers, including systematic reviews, meta-analyses, and clinical modeling studies, confirm that PrEP substantially reduces the risk of HIV acquisition when taken effectively. There are no papers refuting its efficacy.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work